Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: A randomized, double-blind trial

Annals of Internal Medicine

Volumn 127, Issue 4, 1997, Pages 267-274

  Raad, Issam ^b   Darouiche, Rabih ^b   Dupuis, Jacques ^b   Abi Said, Dima ^b   Gabrielli, Andrea ^b   Hachem, Ray ^b   Wall, Matthew ^b   Harris, Richard ^b   Jones, James ^b   Buzaid, Antonio ^b   Robertson, Claudia ^b   Shenaq, Salwa ^b   Curling, Patrick ^b   Burke, Thomas ^b   Ericsson, Charles ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

EID: 0030753776     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-127-4-199708150-00002     Document Type: Article

References (37)

1. Maki DG. Infections due to infusion therapy. In: Bennett JV, Brachman PS, eds. Hospital Infections. Boston: Little, Brown; 1992:849-98.
2. Maki DG. Pathogenesis, prevention, and management of infections due to intravascular devices used for infusion therapy. In: Bisno SL, Waldvogel FA, eds. Infections Associated with Indwelling Medical Devices. Washington, DC: American Society for Microbiology; 1989:161-77.
3. Jarvis WR, Edwards JR, Culver DH, Hughes JM, Horan T, Emori TG, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States National Nosocomial Infection Surveillance System. Am J Med. 1991;91(Suppl 3B):185S-91S.
4. Levy RS, Goldstein J. Value of a topical antibiotic ointment in reducing bacterial colonization of percutaneous venous catheters. Journal of the Albert Einstein Medical Center. 1979;18:67-70
5. Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med. 1981;70:739-44.
6. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339-43.
7. Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol. 1990;8:1591-7.
8. Kamal GD, Pfaller MA, Rempe LE, Jebson PJ. Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA. 1991;265:2364-8.
9. Maki DG, Wheeler SJ, Stolz SM. Study of a novel antiseptic-coated central venous catheter [Abstract]. Crit Care Med. 1991;19(Suppl):S99. [Published as Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997;127:257-66.]
10. Maki DG, Wheeler SJ, Stolz SM. Study of a novel antiseptic-coated central venous catheter [Abstract]. Crit Care Med. 1991;19(Suppl):S99. [Published as Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997;127:257-66.]
11. Raad I, Darouiche R, Hachem R, Sacilowski M, Bodey GP. Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother. 1995;39:2397-400.
12. Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad-spectrum activity and efficacy of catheters coated with minocydine and rifampin. J Infect Dis. 1996;173:418-24.
13. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infections. N Engl J Med. 1977;296: 1305-9.
14. Sherertz RJ, Raad II, Balani A, Koo LC, Rand KH, Pickett DL, et al. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol. 1990;28:76-82.
15. Raad II, Sabbagh MF, Rand KH, Sherertz RJ. Quantitative tip culture methods and the diagnosis of central venous catheter-related infections. Diagn Microbiol Infect Dis. 1991;15:13-20.
16. Raad II, Baba M, Bodey GP. Diagnosis of catheter-related infections: the role of surveillance and targeted quantitative skin cultures. Clin Infect Dis. 1995;20:593-7.
17. Sherertz RJ, Carruth WA, Hampton AA, Byron MP, Solomon DD. Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J Infect Dis. 1993;167:98-106.
18. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 2d ed. v 10. Approved standard NCCLS document M7-A2. Villanova, PA: National Committee for Clinical Laboratory Standards; 1990.
19. Centers for Disease Control and Prevention Draft Guidelines for Prevention of Intravascular Device-Related Infections: Part 1. Intravascular device-related infections: an overview; Part 2. Recommendations for prevention of intravascular device-related infections: notice of comment period. Federal Register. 1995;60:49978-50006.
20. Maslow JN, Sultsky AM, Arbeit RD. Application of pulsed-field gel electrophoresis to molecular epidemiology. In: Persing DH, Smith TF, Tenover FC, White TJ, eds. Diagnostic Molecular Microbiology: Principles and Applications. Washington, DC: American Society for Microbiology; 1993:563-72.
21. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271:1598-601.
22. Heiselman D. Nosocomial bloodstream infections in the critically ill [Letter]. JAMA. 1994;272:1819-20.
23. Minuth JN, Holmes TM, Musher DM. Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and -resistant staphylococci. Antimicrob Agents Chemother. 1974;6:411-4.
24. Lawlor MT, Sullivan MC, Levitz RE, Quintiliani R, Nightingale C. Treatment of prosthetic valve endocarditis due to methicillin-resistant Staphylococcus aureus with minocycline. J Infect Dis. 1990;161:812-4.
25. Yuk JH, Dignani MC, Harris RL, Bradshaw MW, Williams TW Jr. Minocycline as an alternative antistaphylococcal agent [Letter]. Rev Infect Dis. 1991;13:1023-4.
26. Zinner SH, Lagast H, Klastersky J. Antistaphylococcal activity of rifampin with other antibiotics. J Infect Dis. 1981;144:375-81.
27. Karchmer AW, Archer GL, Dismukes WE. Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis. Rev Infect Dis. 1983;5(Suppl 3):S543-8.
28. Klastersky J, Daneau D. Bacteriological evaluation of minocycline, a new tetracycline. Chemotherapy. 1972;17:51-8.
29. Morris AB, Brown RB, Sands M. Use of rifampin in nonstaphylococcal, nonmycobacterial disease. Antimicrob Agents Chemother. 1993;37:1-7.
30. Waterworth PM. The effect of minocycline on Candida albicans. J Clin Pathol. 1974;27:269-72.
31. Graybill JR, Ahrens J. Interaction of rifampin with other antifungal agents in experimental murine candidiasis. Rev Infect Dis. 1983;5(Suppl 3):S620-5.
32. Segreti J, Gvazdinskas LC, Trenholme GM. In vitro activity of minocycline and rifampin against staphylococci. Diagn Microbiol Infect Dis. 1989;12: 253-5.
33. Yourassowky E, van der Linden MP, Lismont MJ, Crokaert F. Combination of minocycline and rifampin against methicillin- and gentamicin-resistant Staphylococcus aureus. J Clin Pathol. 1981;34:559-63.
34. Darouiche RO, Raad II, Bodey GP, Musher DM. Antibiotic susceptibility of staphylococcal isolates from patients with vascular catheter-related bacteremia: potential role of the combination of minocycline and rifampin. Int J Antimicrob Agents. 1995;6:31-6.
35. Mandell GL. The antimicrobial activity of rifampin: emphasis on the relation to phagocytes. Rev Infect Dis. 1983;5(Suppl 3):S463-7.
36. Sande MA. The use of rifampin in the treatment of nontuberculous infections: an overview. Rev Infect Dis. 1983;5(Suppl 3):S399-401.
37. Raad M, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994;15:231-8.